|

Metatranscriptomic Markers of Colonic Neoplasia

RECRUITINGSponsored by Viome
Actively Recruiting
SponsorViome
Started2025-12-20
Est. completion2027-01-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site

Summary

This study is a collaboration between Viome Life Sciences and Scripps Research Institute to develop and validate a noninvasive molecular diagnostic test for the detection of colorectal polyps. Approximately 1,000 participants undergoing colonoscopy will provide saliva and stool samples prior to their procedure. Molecular features identified in these samples will be evaluated in relation to colonoscopy findings to develop a predictive model for colorectal polyp detection. The resulting model will then be evaluated in an independent validation dataset to assess its performance for identifying individuals with colorectal polyps.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Male or female, aged 18 years or older
* Undergoing colonoscopy with bowel preparation
* Able to provide stool and saliva samples prior to colonoscopy
* No stoma present
* No known personal history of colorectal cancer

Exclusion Criteria:

* Individuals under 18 years of age
* Patients with a stoma
* Personal history of colorectal cancer

Conditions2

CancerColorectal Polyps

Locations1 site

Viome Life Sciences
Bothell, Washington, 98011
Momchilo Vuyisich, PhD855-958-4663studies@viome.com

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.